Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Emerging infectious diseases Ročník 21; číslo 1; s. 115 - 118
Hlavní autori: Gamougam, Kadidja, Daugla, Doumagoum M., Toralta, Jacques, Ngadoua, Cyriaque, Fermon, Florence, Page, Anne-Laure, Djingarey, Mamoudou H., Caugant, Dominique A., Manigart, Olivier, Trotter, Caroline L., Stuart, James M., Greenwood, Brian M.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States U.S. National Center for Infectious Diseases 01.01.2015
Centers for Disease Control and Prevention
Predmet:
Adolescent
Adult
Africa
bacteria
Chad
Chad - epidemiology
Child
Child, Preschool
Conjugate vaccines
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
Dispatch
Epidemics
Humans
Infant
Meningitis
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - immunology
Meningitis, Meningococcal - prevention & control
meningococcal
Meningococcal Vaccines - administration & dosage
Patient outcomes
Prevention
serogroup A
Vaccination
vaccine
Young Adult
Chad
ISSN:1080-6040, 1080-6059, 1080-6059
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid2101.140256